0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Spinal Muscular Atrophy (SMA) - Pipeline Insight, 2019
Published Date: March 2019
|
Report Code: DELV-Pipe-119
Home | Market Reports | Health | Health Conditions | Neurological Conditions
Spinal Muscular Atrophy Pipeline Insight 2019

Spinal Muscular Atrophy (SMA) - Pipeline Insight, 2019

Code: DELV-Pipe-119
Report
March 2019
Pages:50
Delveinsight
Description
Table of Content
Tables & Figures

"Spinal Muscular Atrophy (SMA) - Pipeline Insight, 2019” report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Spinal Muscular Atrophy (SMA) development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

Pipeline Products covered across the following Developmental Stages:
• Clinical
• Non-clinical
• Inactive: Discontinued and/or Dormant

Descriptive coverage of pipeline development activities for Spinal Muscular Atrophy (SMA)
Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

Pipeline Therapeutics assessment of products for Spinal Muscular Atrophy (SMA)
The report assesses the active Spinal Muscular Atrophy (SMA) pipeline products by developmental stage, product type, molecule type, and administration route.

Methodology
Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by DelveInsight’s team of industry experts.
Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

Scope of the report
• The report provides a snapshot of the pipeline development for the Spinal Muscular Atrophy (SMA)
• The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for the Spinal Muscular Atrophy (SMA)
• The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Spinal Muscular Atrophy (SMA)
• The report also covers the dormant and discontinued pipeline projects related to the Spinal Muscular Atrophy (SMA)

Reasons to Buy
• Establish comprehensive understanding of the pipeline activity across this Spinal Muscular Atrophy (SMA) to formulate effective R&D strategies
• Gather information of the emerging competitors having potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage
• Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine
• Plot corrective measures for pipeline projects by understanding the pipeline depth and focus of Spinal Muscular Atrophy (SMA) therapeutics
• Devise in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
• Modify the therapeutic portfolio by identifying inactive projects and understanding the factors that might have halted their progress

1. Report Introduction
2. Spinal Muscular Atrophy (SMA) Overview
3. Pipeline Therapeutics
• An Overview of Pipeline Products for Spinal Muscular Atrophy (SMA)
4. Comparative Analysis
5. Products in Clinical Stage
5.1 Drug Name : Company Name
• Product Description
• Research and Development
• Product Development Activities
6. Products in Pre-Clinical and Discovery Stage
6.1 Drug Name : Company Name
• Product Description
• Research and Development
• Product Development Activities
7. Therapeutic Assessment
• Assessment by Route of Administration
• Assessment by Stage and Route of Administration
• Assessment by Molecule Type
• Assessment by Stage and Molecule Type
8. Inactive Products
8.1 Drug Name : Company Name
• Product Description
• Research and Development
• Product Development Activities
Appendix
Report Methodology
Consulting Services
Disclaimer
About DelveInsight

LIST OF TABLES :

Table 1: Total Products for Spinal Muscular Atrophy (SMA)
Table 2: Products in Clinical Stage
Table 3: Products in Non-clinical Stage
Table 4: Assessment by Route of Administration
Table 5: Assessment by Stage and Route of Administration
Table 6: Assessment by Molecule Type
Table 7: Assessment by Stage and Molecule Type
Table 8: Inactive Products

LIST OF FIGURES :

Figure 1: Total Products for Spinal Muscular Atrophy (SMA)
Figure 2: Products in Clinical Stage
Figure 3: Products in Non-clinical Stage
Figure 4: Assessment by Route of Administration
Figure 5: Assessment by Stage and Route of Administration
Figure 6: Assessment by Molecule Type
Figure 7: Assessment by Stage and Molecule Type
Figure 8: Inactive Products

SELECT A FORMAT
Added to Cart
Electronic (PDF)

$1250

This license allows only one user to access the PDF.
Electronic (PDF)

$2500

This license allows all the users of an enterprise residing in one location to access the PDF
Electronic (PDF)

$4000

This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
SIS Group of Schools
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Devic’s Syndrome (Neuromyelitis Optica) Treatment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-0Z7790
Thu Feb 08 00:00:00 UTC 2024

Add to Cart

Global Brain Pacemaker Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-18F7473
Mon Feb 05 00:00:00 UTC 2024

Add to Cart

Global Peripheral Nerve Stimulators Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-23I9151
Fri Feb 02 00:00:00 UTC 2024

Add to Cart

Global Medical Cerebral Spinal Fluid (CSF) Shunt Systems Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-38F16307
Thu Feb 01 00:00:00 UTC 2024

Add to Cart